Founders Financial Securities’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,247
Closed -$216K – 586
2026
Q2
$216K Buy
+2,247
New +$196K 0.01% 522

Other funds holding BBP

Founders Financial Securities's BBP Position: Q3 2026 in Review

Founders Financial Securities sold out of Virtus Biotech ETF (BBP) in Q3 2026, closing a stake of 2,247 shares — an estimated $216K sold.

Founders Financial Securities first reported a position in BBP in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 33 funds tracked by Wall St. Rank hold BBP as of Q3 2026.

  • Founders Financial Securities reported no remaining Virtus Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Founders Financial Securities sold 2,247 Virtus Biotech ETF shares in Q3 2026, an estimated $216K.
  • Founders Financial Securities first reported a position in Virtus Biotech ETF in Q2 2026 and held it in 1 quarter.
  • Founders Financial Securities's Virtus Biotech ETF position peaked at $216K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.

Based on Founders Financial Securities's 13F filing for Q3 2026, filed 28 Oct 2026.